Global Age-Related Macular Degeneration (AMD) Therapeutics Market Research Report 2026(Status and Outlook)
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 8553.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Age-Related Macular Degeneration (AMD) Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Age-Related Macular Degeneration (AMD) Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Age-Related Macular Degeneration (AMD) Therapeutics market.
Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Market Segmentation (by Type)
Wet AMD
Dry AMD
Market Segmentation (by Application)
Hospital
Clinic
Research Institute
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) Therapeutics Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Age-Related Macular Degeneration (AMD) Therapeutics market size was estimated at USD 8553.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Age-Related Macular Degeneration (AMD) Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Age-Related Macular Degeneration (AMD) Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Age-Related Macular Degeneration (AMD) Therapeutics market.
Global Age-Related Macular Degeneration (AMD) Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Market Segmentation (by Type)
Wet AMD
Dry AMD
Market Segmentation (by Application)
Hospital
Clinic
Research Institute
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Age-Related Macular Degeneration (AMD) Therapeutics Market
Overview of the regional outlook of the Age-Related Macular Degeneration (AMD) Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Age-Related Macular Degeneration (AMD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Age-Related Macular Degeneration (AMD) Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Therapeutics
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Age-Related Macular Degeneration (AMD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Age-Related Macular Degeneration (AMD) Therapeutics Market Competitive Situation and Trends
3.8.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Age-Related Macular Degeneration (AMD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2020-2025)
6.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Price by Type (2020-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region
8.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.3.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.4.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.5.2 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.6.2 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.7.2 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Therapeutics by Region(2020-2025)
9.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (2020-2025)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Age-Related Macular Degeneration (AMD) Therapeutics Production (2020-2025)
9.7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc.
10.1.1 Amgen Inc. Basic Information
10.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.1.4 Amgen Inc. Business Overview
10.1.5 Amgen Inc. SWOT Analysis
10.1.6 Amgen Inc. Recent Developments
10.2 Bausch Health Companies, Inc.
10.2.1 Bausch Health Companies, Inc. Basic Information
10.2.2 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.2.4 Bausch Health Companies, Inc. Business Overview
10.2.5 Bausch Health Companies, Inc. SWOT Analysis
10.2.6 Bausch Health Companies, Inc. Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Basic Information
10.4.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.4.4 Novartis AG Business Overview
10.4.5 Novartis AG Recent Developments
10.5 Regeneron Pharmaceuticals Inc.
10.5.1 Regeneron Pharmaceuticals Inc. Basic Information
10.5.2 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.5.4 Regeneron Pharmaceuticals Inc. Business Overview
10.5.5 Regeneron Pharmaceuticals Inc. Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2026-2035)
12.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2026-2035)
12.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Age-Related Macular Degeneration (AMD) Therapeutics
1.2 Key Market Segments
1.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type
1.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Product Life Cycle
3.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Age-Related Macular Degeneration (AMD) Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Age-Related Macular Degeneration (AMD) Therapeutics Market Competitive Situation and Trends
3.8.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Age-Related Macular Degeneration (AMD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Age-Related Macular Degeneration (AMD) Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2020-2025)
6.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Price by Type (2020-2025)
7 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Sales by Application (2020-2025)
7.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
8 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET SALES BY REGION
8.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region
8.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.3.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.4.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.5.2 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country
8.6.2 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region
8.7.2 Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Age-Related Macular Degeneration (AMD) Therapeutics by Region(2020-2025)
9.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Production
9.4.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production
9.5.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (2020-2025)
9.6.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Age-Related Macular Degeneration (AMD) Therapeutics Production (2020-2025)
9.7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Age-Related Macular Degeneration (AMD) Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc.
10.1.1 Amgen Inc. Basic Information
10.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.1.4 Amgen Inc. Business Overview
10.1.5 Amgen Inc. SWOT Analysis
10.1.6 Amgen Inc. Recent Developments
10.2 Bausch Health Companies, Inc.
10.2.1 Bausch Health Companies, Inc. Basic Information
10.2.2 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.2.4 Bausch Health Companies, Inc. Business Overview
10.2.5 Bausch Health Companies, Inc. SWOT Analysis
10.2.6 Bausch Health Companies, Inc. Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Basic Information
10.4.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.4.4 Novartis AG Business Overview
10.4.5 Novartis AG Recent Developments
10.5 Regeneron Pharmaceuticals Inc.
10.5.1 Regeneron Pharmaceuticals Inc. Basic Information
10.5.2 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
10.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Market Performance
10.5.4 Regeneron Pharmaceuticals Inc. Business Overview
10.5.5 Regeneron Pharmaceuticals Inc. Recent Developments
11 AGE-RELATED MACULAR DEGENERATION (AMD) THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast
11.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region
11.2.4 South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2026-2035)
12.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2026-2035)
12.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 5. Age-Related Macular Degeneration (AMD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2025)
Table 11. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Type (K MT)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2020-2025)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Application
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2020-2025)
Table 39. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025)
Table 44. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Inc. Basic Information
Table 63. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 64. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Inc. Business Overview
Table 66. Amgen Inc. SWOT Analysis
Table 67. Amgen Inc. Recent Developments
Table 68. Bausch Health Companies, Inc. Basic Information
Table 69. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 70. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bausch Health Companies, Inc. Business Overview
Table 72. Bausch Health Companies, Inc. SWOT Analysis
Table 73. Bausch Health Companies, Inc. Recent Developments
Table 74. F. Hoffmann-La Roche Ltd. Basic Information
Table 75. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 76. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. F. Hoffmann-La Roche Ltd. Business Overview
Table 78. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments
Table 80. Novartis AG Basic Information
Table 81. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 82. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Recent Developments
Table 85. Regeneron Pharmaceuticals Inc. Basic Information
Table 86. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 87. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Regeneron Pharmaceuticals Inc. Business Overview
Table 89. Regeneron Pharmaceuticals Inc. Recent Developments
Table 90. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Age-Related Macular Degeneration (AMD) Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 5. Age-Related Macular Degeneration (AMD) Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2025)
Table 11. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Type (K MT)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (M USD)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2020-2025)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) by Application
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2020-2025)
Table 39. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025)
Table 44. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Inc. Basic Information
Table 63. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 64. Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Inc. Business Overview
Table 66. Amgen Inc. SWOT Analysis
Table 67. Amgen Inc. Recent Developments
Table 68. Bausch Health Companies, Inc. Basic Information
Table 69. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 70. Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bausch Health Companies, Inc. Business Overview
Table 72. Bausch Health Companies, Inc. SWOT Analysis
Table 73. Bausch Health Companies, Inc. Recent Developments
Table 74. F. Hoffmann-La Roche Ltd. Basic Information
Table 75. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 76. F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. F. Hoffmann-La Roche Ltd. Business Overview
Table 78. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments
Table 80. Novartis AG Basic Information
Table 81. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 82. Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Recent Developments
Table 85. Regeneron Pharmaceuticals Inc. Basic Information
Table 86. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Overview
Table 87. Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Regeneron Pharmaceuticals Inc. Business Overview
Table 89. Regeneron Pharmaceuticals Inc. Recent Developments
Table 90. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 91. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 92. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 93. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 95. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 97. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 99. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 101. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 102. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 103. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 104. Global Age-Related Macular Degeneration (AMD) Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 105. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 106. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Product Life Cycle
Figure 13. Age-Related Macular Degeneration (AMD) Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 19. Global Age-Related Macular Degeneration (AMD) Therapeutics Market PEST Analysis
Figure 20. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2025
Figure 29. Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2020-2025)
Figure 30. Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application
Figure 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application in 2025
Figure 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 45. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 55. Germany Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region in 2024
Figure 68. China Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 82. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Age-Related Macular Degeneration (AMD) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Product Life Cycle
Figure 13. Age-Related Macular Degeneration (AMD) Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Age-Related Macular Degeneration (AMD) Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Age-Related Macular Degeneration (AMD) Therapeutics
Figure 19. Global Age-Related Macular Degeneration (AMD) Therapeutics Market PEST Analysis
Figure 20. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type
Figure 27. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2025
Figure 29. Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type (2020-2025)
Figure 30. Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application
Figure 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application in 2025
Figure 37. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 45. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Age-Related Macular Degeneration (AMD) Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Age-Related Macular Degeneration (AMD) Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Age-Related Macular Degeneration (AMD) Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 55. Germany Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region in 2024
Figure 68. China Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Country in 2024
Figure 82. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Age-Related Macular Degeneration (AMD) Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Age-Related Macular Degeneration (AMD) Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2026-2035)
